Its wellness, delivered with intention and precision
Medical authorities emphasize that investigational drugs should remain within clinical trials and that consumers should avoid black-market products because of unknown composition, dosing, sterility, and safety
[1] [3] The medication works by mimicking the incretin hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways
Early data and smaller studies on GLP-1s suggest that these drugs can improve insulin sensitivity and stabilize blood glucose even before significant weight loss occurs, which may be beneficial to some people
However, their benefits extend beyond blood sugar control, offering promising results for weight management, cardiovascular health, and even cognitive function
Ongoing clinical trials in peripheral vascular disease, neuropsychiatric and substance use disorders, metabolic liver disease, arthritis, hypertension and neurodegenerative disorders may broaden indications for GLP-1-based therapeutics
